Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Pseudomonas aeruginosa AlgR Phosphorylation Status Differentially Regulates Pyocyanin and Pyoverdine Production.

Little AS, Okkotsu Y, Reinhart AA, Damron FH, Barbier M, Barrett B, Oglesby-Sherrouse AG, Goldberg JB, Cody WL, Schurr MJ, Vasil ML, Schurr MJ.

MBio. 2018 Jan 30;9(1). pii: e02318-17. doi: 10.1128/mBio.02318-17.

2.

Crystal Structure of a Hidden Protein, YcaC, a Putative Cysteine Hydrolase from Pseudomonas aeruginosa, with and without an Acrylamide Adduct.

Grøftehauge MK, Truan D, Vasil A, Denny PW, Vasil ML, Pohl E.

Int J Mol Sci. 2015 Jul 14;16(7):15971-84. doi: 10.3390/ijms160715971.

3.

Corrigendum to "High-level over-expression, purification, and crystallization of a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa" [Protein Expr. Purif. 90 (2013) 40-46].

Truan D, Vasil A, Stonehouse M, Vasil ML, Pohl E.

Protein Expr Purif. 2015 Apr;108:115. doi: 10.1016/j.pep.2014.08.008. Epub 2014 Aug 15. No abstract available.

5.

Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa.

Wiens JR, Vasil AI, Schurr MJ, Vasil ML.

MBio. 2014 Feb 4;5(1):e01010-13. doi: 10.1128/mBio.01010-13.

6.

The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa.

Oglesby-Sherrouse AG, Djapgne L, Nguyen AT, Vasil AI, Vasil ML.

Pathog Dis. 2014 Apr;70(3):307-20. doi: 10.1111/2049-632X.12132. Epub 2014 Feb 10.

7.

Recruitment of a phospholipase C/sphingomyelinase into non-lamellar lipid droplets during hydrolysis of lipid bilayers.

Ibarguren M, Sot J, Montes LR, Vasil AI, Vasil ML, Goñi FM, Alonso A.

Chem Phys Lipids. 2013 Jan;166:12-7. doi: 10.1016/j.chemphyslip.2012.12.001. Epub 2012 Dec 17.

8.

High-level over-expression, purification, and crystallization of a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa.

Truan D, Vasil A, Stonehouse M, Vasil ML, Pohl E.

Protein Expr Purif. 2013 Jul;90(1):40-6. doi: 10.1016/j.pep.2012.11.005. Epub 2012 Nov 29. Erratum in: Protein Expr Purif. 2015 Apr;108:115.

9.

Identification and evaluation of twin-arginine translocase inhibitors.

Vasil ML, Tomaras AP, Pritchard AE.

Antimicrob Agents Chemother. 2012 Dec;56(12):6223-34. doi: 10.1128/AAC.01575-12. Epub 2012 Sep 24.

10.

Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.

Young RL, Malcolm KC, Kret JE, Caceres SM, Poch KR, Nichols DP, Taylor-Cousar JL, Saavedra MT, Randell SH, Vasil ML, Burns JL, Moskowitz SM, Nick JA.

PLoS One. 2011;6(9):e23637. doi: 10.1371/journal.pone.0023637. Epub 2011 Sep 1.

11.

The lipase LipA (PA2862) but not LipC (PA4813) from Pseudomonas aeruginosa influences regulation of pyoverdine production and expression of the sigma factor PvdS.

Funken H, Knapp A, Vasil ML, Wilhelm S, Jaeger KE, Rosenau F.

J Bacteriol. 2011 Oct;193(20):5858-60. doi: 10.1128/JB.05765-11. Epub 2011 Aug 12.

12.

Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei.

Rholl DA, Papp-Wallace KM, Tomaras AP, Vasil ML, Bonomo RA, Schweizer HP.

Front Microbiol. 2011 Jul 1;2:139. doi: 10.3389/fmicb.2011.00139. eCollection 2011.

13.

Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.

Wargo MJ, Gross MJ, Rajamani S, Allard JL, Lundblad LK, Allen GB, Vasil ML, Leclair LW, Hogan DA.

Am J Respir Crit Care Med. 2011 Aug 1;184(3):345-54. doi: 10.1164/rccm.201103-0374OC. Epub 2011 May 11.

14.

Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains.

Ibarguren M, López DJ, Montes LR, Sot J, Vasil AI, Vasil ML, Goñi FM, Alonso A.

J Lipid Res. 2011 Apr;52(4):635-45. doi: 10.1194/jlr.M012591. Epub 2011 Jan 20.

16.

Multiple phospholipid substrates of phospholipase C/sphingomyelinase HR2 from Pseudomonas aeruginosa.

López DJ, Collado MI, Ibarguren M, Vasil AI, Vasil ML, Goñi FM, Alonso A.

Chem Phys Lipids. 2011 Jan;164(1):78-82. doi: 10.1016/j.chemphyslip.2010.11.001. Epub 2010 Nov 10.

PMID:
21073866
17.

Characterization of a heme-regulated non-coding RNA encoded by the prrF locus of Pseudomonas aeruginosa.

Oglesby-Sherrouse AG, Vasil ML.

PLoS One. 2010 Apr 8;5(4):e9930. doi: 10.1371/journal.pone.0009930.

18.

End-products diacylglycerol and ceramide modulate membrane fusion induced by a phospholipase C/sphingomyelinase from Pseudomonas aeruginosa.

Ibarguren M, Bomans PH, Frederik PM, Stonehouse M, Vasil AI, Vasil ML, Alonso A, Goñi FM.

Biochim Biophys Acta. 2010 Jan;1798(1):59-64. doi: 10.1016/j.bbamem.2009.10.017. Epub 2009 Nov 3.

19.

A complex extracellular sphingomyelinase of Pseudomonas aeruginosa inhibits angiogenesis by selective cytotoxicity to endothelial cells.

Vasil ML, Stonehouse MJ, Vasil AI, Wadsworth SJ, Goldfine H, Bolcome RE 3rd, Chan J.

PLoS Pathog. 2009 May;5(5):e1000420. doi: 10.1371/journal.ppat.1000420. Epub 2009 May 8.

20.

Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides.

Jiang Z, Vasil AI, Hale J, Hancock RE, Vasil ML, Hodges RS.

Adv Exp Med Biol. 2009;611:561-2. No abstract available.

PMID:
19400313
21.

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy.

Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA.

J Med Microbiol. 2009 Apr;58(Pt 4):492-502. doi: 10.1099/jmm.0.005728-0.

22.

The Metal-Dependent Regulators FurA and FurB from Mycobacterium Tuberculosis.

Lucarelli D, Vasil ML, Meyer-Klaucke W, Pohl E.

Int J Mol Sci. 2008 Aug;9(8):1548-60. doi: 10.3390/ijms9081548. Epub 2008 Aug 28.

23.

Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin.

Parker SK, Barkley RM, Rino JG, Vasil ML.

PLoS One. 2009;4(1):e4281. doi: 10.1371/journal.pone.0004281. Epub 2009 Jan 26.

24.

Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides.

Jiang Z, Kullberg BJ, van der Lee H, Vasil AI, Hale JD, Mant CT, Hancock RE, Vasil ML, Netea MG, Hodges RS.

Chem Biol Drug Des. 2008 Dec;72(6):483-95. doi: 10.1111/j.1747-0285.2008.00728.x.

25.

Ceramide-enriched membrane domains in red blood cells and the mechanism of sphingomyelinase-induced hot-cold hemolysis.

Montes LR, López DJ, Sot J, Bagatolli LA, Stonehouse MJ, Vasil ML, Wu BX, Hannun YA, Goñi FM, Alonso A.

Biochemistry. 2008 Oct 28;47(43):11222-30. doi: 10.1021/bi801139z. Epub 2008 Oct 1.

26.

The influence of iron on Pseudomonas aeruginosa physiology: a regulatory link between iron and quorum sensing.

Oglesby AG, Farrow JM 3rd, Lee JH, Tomaras AP, Greenberg EP, Pesci EC, Vasil ML.

J Biol Chem. 2008 Jun 6;283(23):15558-67. doi: 10.1074/jbc.M707840200. Epub 2008 Apr 18.

27.

Pseudomonas aeruginosa twitching motility-mediated chemotaxis towards phospholipids and fatty acids: specificity and metabolic requirements.

Miller RM, Tomaras AP, Barker AP, Voelker DR, Chan ED, Vasil AI, Vasil ML.

J Bacteriol. 2008 Jun;190(11):4038-49. doi: 10.1128/JB.00129-08. Epub 2008 Apr 4.

28.
29.

Leakage-free membrane fusion induced by the hydrolytic activity of PlcHR(2), a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa.

Montes LR, Ibarguren M, Goñi FM, Stonehouse M, Vasil ML, Alonso A.

Biochim Biophys Acta. 2007 Oct;1768(10):2365-72. Epub 2007 May 5.

30.

Characterization of two distinct phospholipase C enzymes from Burkholderia pseudomallei.

Korbsrisate S, Tomaras AP, Damnin S, Ckumdee J, Srinon V, Lengwehasatit I, Vasil ML, Suparak S.

Microbiology. 2007 Jun;153(Pt 6):1907-15.

PMID:
17526847
31.

Purification and characterization of mycobacterial phospholipase A: an activity associated with mycobacterial cutinase.

Parker SK, Curtin KM, Vasil ML.

J Bacteriol. 2007 Jun;189(11):4153-60. Epub 2007 Apr 6.

32.

How we learnt about iron acquisition in Pseudomonas aeruginosa: a series of very fortunate events.

Vasil ML.

Biometals. 2007 Jun;20(3-4):587-601. Epub 2006 Dec 22. Review.

PMID:
17186376
33.

Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.

Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.

Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.

34.

Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides.

Chen Y, Vasil AI, Rehaume L, Mant CT, Burns JL, Vasil ML, Hancock RE, Hodges RS.

Chem Biol Drug Des. 2006 Feb;67(2):162-73.

35.
36.

Iron and Pseudomonas aeruginosa biofilm formation.

Banin E, Vasil ML, Greenberg EP.

Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11076-81. Epub 2005 Jul 25.

37.

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils.

Walker TS, Tomlin KL, Worthen GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML, Nick JA.

Infect Immun. 2005 Jun;73(6):3693-701.

38.

Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.

Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.

J Biol Chem. 2005 Apr 1;280(13):12316-29. Epub 2005 Jan 27.

39.

A novel extracellular phospholipase C of Pseudomonas aeruginosa is required for phospholipid chemotaxis.

Barker AP, Vasil AI, Filloux A, Ball G, Wilderman PJ, Vasil ML.

Mol Microbiol. 2004 Aug;53(4):1089-98.

40.

Analysis of a novel prophage-encoded group A Streptococcus extracellular phospholipase A(2).

Nagiec MJ, Lei B, Parker SK, Vasil ML, Matsumoto M, Ireland RM, Beres SB, Hoe NP, Musser JM.

J Biol Chem. 2004 Oct 29;279(44):45909-18. Epub 2004 Aug 10.

41.

Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis.

Wilderman PJ, Sowa NA, FitzGerald DJ, FitzGerald PC, Gottesman S, Ochsner UA, Vasil ML.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9792-7. Epub 2004 Jun 21.

42.

FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa.

Ghysels B, Dieu BT, Beatson SA, Pirnay JP, Ochsner UA, Vasil ML, Cornelis P.

Microbiology. 2004 Jun;150(Pt 6):1671-80.

44.

Purification, characterization, and identification of a sphingomyelin synthase from Pseudomonas aeruginosa. PlcH is a multifunctional enzyme.

Luberto C, Stonehouse MJ, Collins EA, Marchesini N, El-Bawab S, Vasil AI, Vasil ML, Hannun YA.

J Biol Chem. 2003 Aug 29;278(35):32733-43. Epub 2003 Jun 10.

45.

DNA microarrays in analysis of quorum sensing: strengths and limitations.

Vasil ML.

J Bacteriol. 2003 Apr;185(7):2061-5. Review. No abstract available.

46.

Architecture of a protein central to iron homeostasis: crystal structure and spectroscopic analysis of the ferric uptake regulator.

Pohl E, Haller JC, Mijovilovich A, Meyer-Klaucke W, Garman E, Vasil ML.

Mol Microbiol. 2003 Feb;47(4):903-15.

47.

A novel class of microbial phosphocholine-specific phospholipases C.

Stonehouse MJ, Cota-Gomez A, Parker SK, Martin WE, Hankin JA, Murphy RC, Chen W, Lim KB, Hackett M, Vasil AI, Vasil ML.

Mol Microbiol. 2002 Nov;46(3):661-76.

48.
49.

Pseudomonas aeruginosa synthesizes phosphatidylcholine by use of the phosphatidylcholine synthase pathway.

Wilderman PJ, Vasil AI, Martin WE, Murphy RC, Vasil ML.

J Bacteriol. 2002 Sep;184(17):4792-9.

50.

Effects of the twin-arginine translocase on secretion of virulence factors, stress response, and pathogenesis.

Ochsner UA, Snyder A, Vasil AI, Vasil ML.

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8312-7. Epub 2002 May 28.

Supplemental Content

Loading ...
Support Center